Elicio Therapeutics (9HA.F) Q2 2024 Earnings

15MayConfirmed
Q2 2024
-1.06
-1.04
-1.02
-1

Details

Expected EPS
-1.0009688
Actual EPS
-1.056068
Surprise EPS
-0.06
Surprise Percent
+5.5%

Description

Elicio Therapeutics (9HA.F) has reported earnings of -1.056068 per share for Q2 2024.

0 Comments

Share your thoughts